Cleaning Validation GMP Under Regulatory Scrutiny

Introduction

During a GMP audit, Cleaning Validation is one of the first dossiers requested.
Not because it is a minor topic, but because it reflects the company’s ability to control contamination risks effectively.

Regulatory Analysis

• EU GMP Annex 15: requirement for HBEL-based limits
• ICH Q9: risk-based approach
• ICH Q10: integration into the Pharmaceutical Quality System (PQS)
• FDA 21 CFR 211.67: written and controlled cleaning procedures

What Inspectors Expect to See

• Scientifically justified MACO calculations
• Recovery studies
• Evidence supporting worst-case selection
• Trending of results over time
• Structured deviation management

How to Avoid Critical Observations

• Always document the scientific rationale
• Demonstrate full lifecycle control
• Integrate change control with Cleaning Validation
• Demonstrate that QA governs the process

Audit Readiness: Essential Documents

• Approved protocol and final report
• Toxicological assessments
• Risk assessments
• Cleaning records and logs
• CAPA and change control documentation

Typical Observation / Corrective Action

Observation: Use of legacy limits without HBEL justification
Corrective Action: Update toxicological evaluation and perform targeted revalidation

Conclusion

Cleaning Validation is a mirror of the quality system.
Keep your organization audit-ready. Discover the complete guide on GuideGxP.com.